Literature DB >> 16177088

Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells.

Sally C Kent1, Yahua Chen, Sue M Clemmings, Vissia Viglietta, Norma Sue Kenyon, Camillo Ricordi, Bernhard Hering, David A Hafler.   

Abstract

Altered frequency and function of peripheral invariant NKT (iNKT) cells have been implicated in the regulation of murine and human type 1a diabetes. To examine regulatory cells from the site of drainage of autoinflammatory tissue and autoantigenic T cell priming in diabetes, we directly cloned iNKT cells from human pancreatic draining lymph nodes (PLN). From 451 T cell clones from control and diabetic PLN, we derived 55 iNKT cells by two methods and analyzed function by cytokine secretion. iNKT cell clones isolated from control PLN secreted IL-4 and IFN-gamma upon TCR stimulation. For type 1a diabetic subjects, PLN iNKT cell clones from three samples secreted IFN-gamma and no IL-4. In a rare recent onset diabetic sample with islet-infiltrating CD4+ T cells, the phenotype of PLN iNKT cell clones was mixed. From normal and diabetic PLN, one-third of CD1d tetramer+-sorted T cell clones were reactive with CD1d transfectants or proliferated/secreted cytokine in response to alpha-galactosylceramide-pulsed PBMCs; tetramer-staining T cell clones from diabetic PLN did not secrete IL-4. This is the first report directly examining iNKT cells from lymph nodes draining the site of autoimmunological attack in humans; iNKT cells were altered in cytokine secretion as previously reported for circulating iNKT cells in human type 1a diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177088     DOI: 10.4049/jimmunol.175.7.4458

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

Review 2.  Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells.

Authors:  Jan Novak; Lucie Novakova
Journal:  Clin Exp Med       Date:  2012-07-24       Impact factor: 3.984

3.  Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine.

Authors:  Tihamer Orban; Janos Tibor Kis
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

Review 4.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

Review 5.  Regulation of type 1 diabetes, tuberculosis, and asthma by parasites.

Authors:  Zhugong Liu; Qian Liu; David Bleich; Padmini Salgame; William C Gause
Journal:  J Mol Med (Berl)       Date:  2009-10-21       Impact factor: 4.599

6.  Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.

Authors:  Rémi J Creusot; Shahriar S Yaghoubi; Keiichi Kodama; Demi N Dang; Vu H Dang; Karine Breckpot; Kris Thielemans; Sanjiv S Gambhir; C Garrison Fathman
Journal:  Clin Immunol       Date:  2008-03-12       Impact factor: 3.969

7.  Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Authors:  Mark A Exley; Runhua Hou; Angela Shaulov; Elena Tonti; Paolo Dellabona; Giulia Casorati; Omid Akbari; H Orhan Akman; Edward A Greenfield; Jenny E Gumperz; Jonathan E Boyson; Steven P Balk; S Brian Wilson
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

8.  Natural killer T cells: drivers or passengers in preventing human disease?

Authors:  Stuart P Berzins; David S Ritchie
Journal:  Nat Rev Immunol       Date:  2014-08-08       Impact factor: 53.106

9.  Natural killer T cell based Immunotherapy.

Authors:  Priyanka B Subrahmanyam; Wenji Sun; James E East; Junxin Li; Tonya J Webb
Journal:  J Vaccines Vaccin       Date:  2012-08-23

10.  Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development.

Authors:  Zachary D Borg; Patrick J Benoit; Graham W J Lilley; Idil Aktan; Alan Chant; Victoria L DeVault; Mercedes Rincon; Jonathan E Boyson
Journal:  J Immunol       Date:  2013-12-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.